U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07774819) titled 'Spatially Fractionated Radiotherapy for Tumor Treatment' on July 11.

Brief Summary: To explore the efficacy and toxicity of spatially fractionated radiotherapy in the treatment of tumors.

Study Start Date: Dec. 19, 2024

Study Type: INTERVENTIONAL

Condition: Radiotherapy-Induced Immune Priming

Intervention: RADIATION: spatially fractionated radiotherapy

spatially fractionated radiotherapy

Recruitment Status: RECRUITING

Sponsor: Xu Zhi-yuan

Information provided by (Responsible Party): Xu Zhi-yuan, The University of Hong Kong-Shenzhen Hospital

Disclaimer: Curated by HT Syndication....